Average cost per year*
Average cost per beneficiary*
This combination medication is used to treat symptoms caused by the common cold, flu, allergies, hay fever, or other breathing illnesses (e.g., sinusitis, bronchitis). Dextromethorphan is a cough suppressant that affects a certain part of the brain (cough center), reducing the urge to cough. Decongestants help relieve stuffy nose symptoms. Antihistamines relieve watery eyes, itchy eyes/nose/throat, runny nose, and sneezing. Cough-and-cold products have not been shown to be safe or effective in children younger than 6 years. Therefore, do not use this product to treat cold symptoms in children younger than 6 years unless specifically directed by the doctor. Some products (such as long-acting tablets/capsules) are not recommended for use in children younger than 12 years. Ask your doctor or pharmacist for more details about using your product safely. These products do not cure or shorten the length of the common cold and may cause serious side effects. To decrease the risk for serious side effects, carefully follow all dosage directions. Do not use this product to make a child sleepy. Do not give other cough-and-cold medication that might contain the same or similar ingredients (see also Drug Interactions section). Ask the doctor or pharmacist about other ways to relieve cough and cold symptoms (such as drinking enough fluids, using a humidifier or saline nose drops/spray). NOTE: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.
*Origin of the terms and chart data used within this page: https://data.cms.gov/
Yes, Brompheniramine-Pseudoephed-DM is covered by Medicare.
In 2021, the average cost per dose of Brompheniramine-Pseudoephed-DM was $0.11.
The average dose of Brompheniramine-Pseudoephed-DM received per year is 27,621 units
284 Medicare beneficiaries received Brompheniramine-Pseudoephed-DM in 2021, which was a -0.01% from 2020
There were 321 claims made by Medicare beneficiaries, which is a -0.03% from 2020
The average spending amount per claim in 2021 was $24.17
The average Medicare spending per beneficiary amount for Brompheniramine-Pseudoephed-DM was $27.32
The most expensive manufacturer of Brompheniramine-Pseudoephed-DM is Perrigo/Padagis
Eywa Pharma Inc is the least expensive manufacturer with an Average Spending Per Dosage Unit of $0.10
Acella Pharmace received $2,114.57
The total amount spent on Brompheniramine-Pseudoephed-DM by Medicare is $7,758.16
Short Term Medical Insurance
Limited Fixed Indemnity Plans